‘We’re 40 Years Behind Them And The Gap Is Growing’ – Burt Calls For European Urgency On Value Added Medicines
Medicines For Europe Sector Chair Sets Out Current Landscape
Europe risks “missing out on a massive opportunity” if it does not improve its efforts to recognize and take advantage of the benefits of value added medicines, according to Medicines for Europe sector chair and Pharmanovia CEO James Burt.
